Category: Alzheimer

Alzheimer

  • ALZHEIMER’S DISEASE AND INOSITOL

    Study: ALZHEIMER’S DISEASE AND INOSITOL “Inositol Treatment of Alzheimer’s Disease: A Double-Blind, Cross-Over Placebo Controlled Trial” Barak, Yoram, et al, Prog. Neuro-Psychopharmacol. and Biological Psychiatry, 1996;20:729-735. In a double-blind crossover study, inositol at 6 grams per day versus glucose for 1 month each was carried out in 11 Alzheimer’s disease patients. There was an overall […] More

  • ALZHEIMER’S DISEASE – VITAMIN E

    Study: ALZHEIMER’S DISEASE – VITAMIN E “Alzheimer’s and Vitamin E” Nutrition Week, May 2, 1997;27(17):7/New York Times, April 24, 1997;A22. Alzheimer’s disease patients were given 2000 IU of vitamin E daily, which is 60 times the RDA, resulting in a significant delay in the progression to 1 of 4 major milestone symptoms: inability to perform […] More

  • Newsletter

  • ALZHEIMER’S DISEASE – DEMENTIA, VITMIN C, ASCORBIC ACID, DEHYDROASCORBATE, FREE RADICALS

    Study: ALZHEIMER’S DISEASE – DEMENTIA, VITMIN C, ASCORBIC ACID, DEHYDROASCORBATE, FREE RADICALS “Ascorbic Acid in Cerebrospinal Fluid – A Possible Protection Against Free Radicals in the Brain” Barabas, Judit, et al, Archives of Gerontology and Geriatrics, 1995;21:43-48. Ascorbic acid and dehydroascorbate levels in the plasma and CSF of 12 patients with senile dementia of moderate […] More

  • ALZHEIMER’S DISEASE, VITAMINS A, E AND CAROTENOIDS

    Study: ALZHEIMER’S DISEASE, VITAMINS A, E AND CAROTENOIDS “Plasma Concentrations of Vitamins A and E and Carotenoids in Alzheimer’s Disease” “Zaman, Z., et al, Age and Ageing, 1992;21:91-94.” This study of Alzheimer’s and multi-infarct dementia patients, compared to nondemented elderly controls, found that in the 20 Alzheimer’s and multi-infarct dementia patients there were significantly lower […] More

  • ALZHEIMER’S DISEASE – THIAMIN, VITAMIN B1

    Study: ALZHEIMER’S DISEASE – THIAMIN, VITAMIN B1 “Thiamine and Alzheimer’s Disease: A Pilot Study” Blass JP, Gleason P, Brush D, et al, Arch Neurol, August, 1988;45:833-835. Seven females and 4 males who were between 59 and 83 years of age with Alzheimer’s disease participated in a double-blind, placebo-controlled, crossover study evaluating the effects of 3 […] More